1887

n Southern African Journal of HIV Medicine - When to start antiretroviral therapy in adults : the results of HPTN 052 move us closer to a 'test-and-treat' policy : opinion

USD

 

Abstract

When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a 'test-and-treat' approach in which anyone who tests HIV-positive is offered ART, irrespective of their CD4 count? The recently announced results of the HPTN 052 trial take us closer, but not all the way, to a test-and-treat approach.

Loading

Article metrics loading...

/content/m_sajhiv/12/3/EJC65577
2011-09-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error